<DOC>
	<DOC>NCT01737996</DOC>
	<brief_summary>The objective of the current trial is to evaluate safety, tolerability and pharmacokinetics of different multiple doses of BI 207127 BID and multiple doses of BI 207127 combined with faldaprevir in healthy male and female subjects.</brief_summary>
	<brief_title>Safety, Tolerability and Pharmacokinetics of Different Multiple Doses of BI 207127 BID and Multiple Doses of BI 207127 Combined With Faldaprevir in Healthy Male and Female Subjects</brief_title>
	<detailed_description />
	<criteria>Inclusion criteria: 1. healthy male and female subjects Exclusion criteria: 1. Any relevant deviation from healthy conditions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>